Geertrui Vanhove

Geertrui Vanhove

Chief Tech/Sci/R&D Officer at
Surrozen Operating, Inc.
61 year
Health Technology
Consumer Services
Finance

Profile

Geertrui Vanhove is currently Chief Medical Officer at Surrozen Operating, Inc. since 2019 and Venture Partner at Longitude Capital Management Co LLC since 2023.
Former positions include Medical Director at Abbott Laboratories from 1996 to 1998, Medical Director at XOMA (US) LLC from 1998 to 2005, Vice President-Clinical Development at NeurogesX, Inc. from 2010 to 2011, Vice President-Medical Affairs at Assertio Therapeutics, Inc. from 2011 to 2012, VP, Head-Research & Development Search at Jazz Pharmaceuticals, Inc. from 2015 to 2019, Chief Medical Officer at Surrozen, Inc. from 2019 to 2021, and Independent Director at INSYS Therapeutics, Inc. from 2018 to 2020.
Education includes an MBA from St. Mary's College (Indiana) and a doctorate from Katholieke Universiteit Leuven.

Geertrui Vanhove active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer 2019-03-31
Private Equity Investor 2023-09-30

Former positions of Geertrui Vanhove

CompaniesPositionEnd
SURROZEN, INC. Chief Tech/Sci/R&D Officer 2021-03-30
INSYS THERAPEUTICS, INC. Director/Board Member 2020-01-31
Chief Tech/Sci/R&D Officer 2019-03-31
Chief Tech/Sci/R&D Officer 2012-04-30
NEUROGESX, INC Corporate Officer/Principal 2011-06-30
See the detail of Geertrui Vanhove's experience

Training of Geertrui Vanhove

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Geertrui Vanhove